loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 21937 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE (1)

filter

01 GILEAD SCIENCES (1)

filter

01 TABLET;ORAL (1)

filter

01 600MG;200MG;300MG (1)

filter

01 USA (1)

URL Supplier Web Content
TABLET;ORAL
600MG;200MG;300MG
ATRIPLA
USA
21937
2006-07-12
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 21937

Looking for CTD TGA MCC DOSSIER APPLICATION 21937 1

19

Gilead Sciences, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE, with a corresponding application number 21937 and regulatory information .

proudly manufactured in the

approval since 2006-07-12

Gilead Sciences's ATRIPLA TABLET;ORAL, medication with 600MG;200MG;300MG of EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE.

Post Enquiry
POST ENQUIRY